JPS58150556A - Preparation of optically active alpha-aminoaldehyde - Google Patents
Preparation of optically active alpha-aminoaldehydeInfo
- Publication number
- JPS58150556A JPS58150556A JP57031818A JP3181882A JPS58150556A JP S58150556 A JPS58150556 A JP S58150556A JP 57031818 A JP57031818 A JP 57031818A JP 3181882 A JP3181882 A JP 3181882A JP S58150556 A JPS58150556 A JP S58150556A
- Authority
- JP
- Japan
- Prior art keywords
- boc
- optically active
- amino
- group
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 claims abstract description 20
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 8
- 125000003118 aryl group Chemical group 0.000 claims abstract description 5
- 108090000765 processed proteins & peptides Chemical group 0.000 claims description 17
- 125000000539 amino acid group Chemical group 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 2
- 125000006242 amine protecting group Chemical group 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract description 4
- 230000001590 oxidative effect Effects 0.000 abstract description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 230000003287 optical effect Effects 0.000 abstract description 3
- VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 abstract description 2
- VGGGPCQERPFHOB-UHFFFAOYSA-N Bestatin Natural products CC(C)CC(C(O)=O)NC(=O)C(O)C(N)CC1=CC=CC=C1 VGGGPCQERPFHOB-UHFFFAOYSA-N 0.000 abstract description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract description 2
- 229950009811 ubenimex Drugs 0.000 abstract description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 150000001299 aldehydes Chemical class 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- -1 α-amino acid ester Chemical class 0.000 description 7
- 235000008206 alpha-amino acids Nutrition 0.000 description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 229940124280 l-arginine Drugs 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 239000002532 enzyme inhibitor Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 2
- 150000001371 alpha-amino acids Chemical class 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZAVSPTOJKOFMTA-SFHVURJKSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(4-phenylmethoxyphenyl)propanoic acid Chemical compound C1=CC(C[C@H](NC(=O)OC(C)(C)C)C(O)=O)=CC=C1OCC1=CC=CC=C1 ZAVSPTOJKOFMTA-SFHVURJKSA-N 0.000 description 1
- BDHUTRNYBGWPBL-HNNXBMFYSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-6-(phenylmethoxycarbonylamino)hexanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CCCCNC(=O)OCC1=CC=CC=C1 BDHUTRNYBGWPBL-HNNXBMFYSA-N 0.000 description 1
- AQTUACKQXJNHFQ-LURJTMIESA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanedioic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CCC(O)=O AQTUACKQXJNHFQ-LURJTMIESA-N 0.000 description 1
- QVHJQCGUWFKTSE-YFKPBYRVSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)OC(C)(C)C QVHJQCGUWFKTSE-YFKPBYRVSA-N 0.000 description 1
- MRXDGVXSWIXTQL-HYHFHBMOSA-N (2s)-2-[[(1s)-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[(2s)-1-oxo-3-phenylpropan-2-yl]amino]pentan-2-yl]amino]-2-oxoethyl]carbamoylamino]-3-phenylpropanoic acid Chemical compound C([C@H](NC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C=O)C1NC(N)=NCC1)C(O)=O)C1=CC=CC=C1 MRXDGVXSWIXTQL-HYHFHBMOSA-N 0.000 description 1
- IJWCGVPEDDQUDE-YGJAXBLXSA-N (2s)-2-[[(1s)-2-[[(2s)-5-amino-1,5-dioxo-1-[[(2s)-1-oxopropan-2-yl]amino]pentan-2-yl]amino]-1-[(6s)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-2-oxoethyl]carbamoylamino]-4-methylpentanoic acid Chemical compound O=C[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)N[C@@H](CC(C)C)C(O)=O)[C@@H]1CCN=C(N)N1 IJWCGVPEDDQUDE-YGJAXBLXSA-N 0.000 description 1
- CQIUZHAQYHXKRY-VIFPVBQESA-N (2s)-2-amino-3-phenylpropanal Chemical compound O=C[C@@H](N)CC1=CC=CC=C1 CQIUZHAQYHXKRY-VIFPVBQESA-N 0.000 description 1
- CNBUSIJNWNXLQQ-NSHDSACASA-N (2s)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CNBUSIJNWNXLQQ-NSHDSACASA-N 0.000 description 1
- RRONHWAVOYADJL-HNNXBMFYSA-N (2s)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 RRONHWAVOYADJL-HNNXBMFYSA-N 0.000 description 1
- FCAJYRVEBULFKS-UHFFFAOYSA-N 2-(oxolan-2-yl)ethanol Chemical compound OCCC1CCCO1 FCAJYRVEBULFKS-UHFFFAOYSA-N 0.000 description 1
- QJYRUYURLPTHLR-YFKPBYRVSA-N 2-[(4s)-4-amino-5-oxopentyl]guanidine Chemical compound O=C[C@@H](N)CCCNC(N)=N QJYRUYURLPTHLR-YFKPBYRVSA-N 0.000 description 1
- QPMCUNAXNMSGTK-UHFFFAOYSA-N 2-aminopropanal Chemical compound CC(N)C=O QPMCUNAXNMSGTK-UHFFFAOYSA-N 0.000 description 1
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 108010087765 Antipain Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- OLVPQBGMUGIKIW-UHFFFAOYSA-N Chymostatin Natural products C=1C=CC=CC=1CC(C=O)NC(=O)C(C(C)CC)NC(=O)C(C1NC(N)=NCC1)NC(=O)NC(C(O)=O)CC1=CC=CC=C1 OLVPQBGMUGIKIW-UHFFFAOYSA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- IJWCGVPEDDQUDE-UHFFFAOYSA-N Elastatinal Natural products O=CC(C)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)NC(CC(C)C)C(O)=O)C1CCN=C(N)N1 IJWCGVPEDDQUDE-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 238000006828 Rosenmund reduction reaction Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- QFAADIRHLBXJJS-ZAZJUGBXSA-N amastatin Chemical compound CC(C)C[C@@H](N)[C@H](O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O QFAADIRHLBXJJS-ZAZJUGBXSA-N 0.000 description 1
- 108010052590 amastatin Proteins 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- MLAPMZGXJGUYNO-INIZCTEOSA-N benzyl n-[(5s)-6-hydroxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]hexyl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@H](CO)CCCCNC(=O)OCC1=CC=CC=C1 MLAPMZGXJGUYNO-INIZCTEOSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 108010086192 chymostatin Proteins 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N cystine group Chemical group C([C@@H](C(=O)O)N)SSC[C@@H](C(=O)O)N LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- NKRNGKIEDAVMHL-UHFFFAOYSA-L dihydroxy(dioxo)chromium;pyridine Chemical compound O[Cr](O)(=O)=O.C1=CC=NC=C1 NKRNGKIEDAVMHL-UHFFFAOYSA-L 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 108010039262 elastatinal Proteins 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000006301 indolyl methyl group Chemical group 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- MJGFBOZCAJSGQW-UHFFFAOYSA-N mercury sodium Chemical compound [Na].[Hg] MJGFBOZCAJSGQW-UHFFFAOYSA-N 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 238000007248 oxidative elimination reaction Methods 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910001023 sodium amalgam Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は光学活性β−アミノアルコール類を原料として
、このものを酸化することにより光学活性α−アミbア
ルデヒド類及びペプチドアルデヒド類の新規製造法に関
する。光学活性α−アミノアルデヒド類はベスタチン、
ペプスタチン、アマスタチン等の合成中間体とし有用な
化合物である。一方光学活性ペプチドアルデヒド類は微
生物が産生ずる酵素阻害剤としてこれまでにロイペプチ
ン、アンチパイン、キモスタチン、エラスタチナールが
見出されているが。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel method for producing optically active α-amino aldehydes and peptide aldehydes by oxidizing optically active β-amino alcohols as raw materials. Optically active α-amino aldehydes are bestatin,
It is a useful compound as a synthetic intermediate for pepstatin, amastatin, etc. On the other hand, among optically active peptide aldehydes, leupeptin, antipain, chymostatin, and elastatinal have been discovered as enzyme inhibitors produced by microorganisms.
これらはC末端残基としてそれぞれアルギニナール、フ
ェニルアラニナール、アラニナールを含んでいる。これ
らの光学活性ペプチドアルデヒド類は各種プロテアーセ
2例えばプラスミン。These contain argininal, phenylalaninal, and alaninal as C-terminal residues, respectively. These optically active peptide aldehydes include various proteases such as plasmin.
トリプシン、パパイン、キモトリプシン、エステラーゼ
等を強く阻害する。″このほかにこれら酵素阻害剤は消
炎作用、抗潰瘍作用、変異誘発阻止、腹水貯留阻止9発
癌ならびに癌転移阻止などをはじめきし、多くの疾病に
対する効果が報告され、近年脚光をあびている。Strongly inhibits trypsin, papain, chymotrypsin, esterase, etc. ``In addition, these enzyme inhibitors have been in the spotlight in recent years as they have been reported to have anti-inflammatory effects, anti-ulcer effects, inhibition of mutation induction, inhibition of ascites accumulation, inhibition of carcinogenesis, and inhibition of cancer metastasis, and are effective against many diseases.
α−アミノアルテヒド類合成の従来方法はα−アミノ酸
誘導体の還元法とα−アミノ酸由来のβ−アミノアルコ
ール類の酸化法によるものに大別できる。還元法として
はN−保護α−アミノ酸エステルのナトリウムアマルガ
ム還元(J、 Biol、 Ohem、、 217巻、
817頁、 1955年)。Conventional methods for synthesizing α-aminoaltehydes can be roughly divided into methods for reducing α-amino acid derivatives and methods for oxidizing β-amino alcohols derived from α-amino acids. As a reduction method, sodium amalgam reduction of N-protected α-amino acid ester (J, Biol, Ohem, Vol. 217,
817 pages, 1955).
水素化ジイソブチルアルミニウム還元(0herrl。Diisobutylaluminum hydride reduction (0herrl.
Pharm、 Bull、、 28巻、 8081頁、
1975年)、N−フタロイル−α−アミノ酸塩化
物のローゼンムント還元(J、 Org、Ohem、、
18巻、297頁、19L3年)。Pharm, Bull, vol. 28, p. 8081,
1975), Rosenmund reduction of N-phthaloyl-α-amino acid chlorides (J. Org.
Volume 18, page 297, 19L3).
N−保護α−アミノ酸ピラゾリドあるいは3,5−ンメ
チルピラゾリドの水素化リチウムアルミニウム還元(A
nn、、 640巻、 IIIJ、 1961年、
J。Lithium aluminum hydride reduction (A
nn,, vol. 640, IIIJ, 1961,
J.
Antibiotics、 29巻、600Q 197
6年、 J、 Med。Antibiotics, Volume 29, 600Q 197
6th year, J, Med.
Chem、、 20巻、 510頁、 1977年
)、N−保護α−アミノ酸イミダゾリドの水素化ジイソ
ブチルアルミニウム還元(J、 O,S、 Ohem、
Oomm、、 79頁。Chem, vol. 20, p. 510, 1977), diisobutylaluminum hydride reduction of N-protected α-amino acid imidazolides (J, O,S, Ohem,
Oomm,, 79 pages.
1979年)及びN−保護α−アミノ酸混合酸無水物の
接触還元(Chem、 Pharm、Bull、、 2
0巻、361頁、 1972年)等が知られているが、
これらはいずれも原料及び副生物の混合物として得られ
。(1979) and catalytic reduction of N-protected α-amino acid mixed acid anhydrides (Chem, Pharm, Bull, 2003).
Volume 0, page 361, 1972) are known, but
All of these are obtained as a mixture of raw materials and by-products.
α−アミノアルデヒド類がシリカゲル等の精製手段に不
安定でラセミ化することから単一の光学的純品としてα
−アミノアルデヒドを得るに至っていない。このため公
知の還元法はα−アミノアルデヒドのアルデヒド部を保
護して精製し、脱保護するという二工程の操作を必要と
し。Since α-aminoaldehydes are unstable to purification methods such as silica gel and racemize, α-aminoaldehydes are used as a single optically pure product.
-Aminoaldehyde has not yet been obtained. For this reason, the known reduction method requires a two-step operation of protecting and purifying the aldehyde moiety of α-aminoaldehyde and deprotecting it.
また収率も低いという欠点を有する。また酸化法として
はβ−アミノアルコール類のフィ、ナー・モファノト酸
化(Ohem、 Pharm、Bull、、 20巻、
361頁、 1972年)、クロム酸−ビリジン酸化(
J、 Org、 Ohem、、 46巻、 4797
頁、 1981年)が知られているが、これらはいず
れも大部分ラセミ化したα−アミノアルデヒド類を得て
いるのみである。またα−アミノ酸より誘導した3−ア
ミノ−1,2−ジオール類の過ヨウ素酸を用いるクリコ
ール酸化開裂により光学活性体を得ている例もあるがα
−アミノ酸からの工程数が長く実用性に乏しく、また−
膜性も確かめられていない(J、 C,S、 Chem
、 Oomm、、 875頁、 1979年)。It also has the disadvantage of low yield. In addition, as an oxidation method, there is a method of oxidation of β-amino alcohols (Ohem, Pharm, Bull, Vol. 20,
361, 1972), chromic acid-pyridine oxidation (
J, Org, Ohem, vol. 46, 4797
Page, 1981), but all of these methods only yield mostly racemized α-aminoaldehydes. There are also examples of optically active forms obtained by glycol oxidative cleavage using periodic acid of 3-amino-1,2-diols derived from α-amino acids.
-The number of steps from amino acids is long and impractical, and-
Membrane properties have not been confirmed (J, C, S, Chem
, Oomm, p. 875, 1979).
以上の如く公知方法は収率が低い、あるいは精製のため
アルデヒド基を保護しなければならなかったり、あるい
は工程数が長いなどの欠点を有し満足し難い方法である
。このためα−アミノアルデヒド類の光学的純品の物性
値等は現在までほとんど知られていない。そこで本発明
者等は種々研究を行なった結果、三酸化イオウ錯体とジ
メチルスルホキシドをトリエチルアミン存在下で光学活
性β−アミノアルコール類あるいはペプチドアルコール
類に作用させ短時間酸化することにより収率良く光学活
性α−アミノアルテヒド類あるいはペプチドアルデヒド
類を光学的純品として得る薪規な製造法を発見し本発明
を完成した。なお、 J、 A、 0.8.、86巻。As described above, the known methods are unsatisfactory due to drawbacks such as low yields, the need to protect aldehyde groups for purification, or a long number of steps. For this reason, the physical properties of optically pure α-aminoaldehydes are largely unknown to date. As a result of various studies, the present inventors found that sulfur trioxide complex and dimethyl sulfoxide were allowed to act on optically active β-amino alcohols or peptide alcohols in the presence of triethylamine to oxidize them for a short period of time, resulting in optical activity with good yield. The present invention was completed by discovering a simple manufacturing method for obtaining optically pure α-amino altehydes or peptide aldehydes. In addition, J, A, 0.8. , 86 volumes.
5505頁、 1967年に記載の如くアルコール類を
酸化してアルデヒド類にする報告は知られているが9本
発明のように光学活性β−アミノアルコール類から光学
活性α−アミノアルテヒト類を製造した報告は未だ見当
らず、しかも本発明方法を行なうことにより後記記載の
様な優れた光学活性α〜ルアミノアルデヒド又はペプチ
ドアルデヒド類の製造が可能となったものである。5505, 1967, there are known reports of oxidizing alcohols to form aldehydes. No report has been found yet, and by carrying out the method of the present invention, it has become possible to produce excellent optically active α-ruamino aldehydes or peptide aldehydes as described below.
本発明方法を化学式で表わすと下式の通りである。The method of the present invention can be expressed as a chemical formula as shown below.
(2)
(式中用はアミノ保護基、アミノ酸残基、ペプチド残基
、官能基の全部又は一部を保護したアミノ酸残基または
ペプチド残基、R2およびR1は水素原子又はアルキル
基、R3は水素原子、アルキル基もしくはアリール基で
あり、アルキル基及びアリール基は無置換であってもよ
く置換されていてもよい。)
なお、R1に係るアミノ保護基としてはペプチド合成等
に通常使用される第三ブトキシカルボニル基、カルボベ
ンゾキシ基、ベンジル基、トシル基等が使用可能である
。また、RAに関しては具体的にメチル、エチル、プロ
ピル、イソプロピル、ブチル、イソブチル、1−メチル
プロピル、カルボキシメチル、0−ベンジル、i−キシ
メチル、β−カルホキジエチル、β−メチルチオエチル
、ベンジル、S−ヘンシルチオメチル。(2) (In the formula, amino protecting group, amino acid residue, peptide residue, amino acid residue or peptide residue with all or part of the functional group protected, R2 and R1 are hydrogen atoms or alkyl groups, R3 is A hydrogen atom, an alkyl group, or an aryl group, and the alkyl group and aryl group may be unsubstituted or substituted.) The amino protecting group for R1 is a group commonly used in peptide synthesis, etc. Tert-butoxycarbonyl group, carbobenzoxy group, benzyl group, tosyl group, etc. can be used. Regarding RA, specific examples include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, 1-methylpropyl, carboxymethyl, 0-benzyl, i-xymethyl, β-carphokidiethyl, β-methylthioethyl, benzyl, S -Hensylthiomethyl.
4−ヘンシルオキシヘンシル、3.4−ジメトキシベン
ジル、イミダソリルメチル、3,4−メチレンジオキシ
ベンジル、フェニル、4−ヘンシルオキシフェニル、N
Y−ニトロクアニジノプロヒル、 N’−Boc−7
ミ/ブチル、NY−BOC−アミノプロピル、インドリ
ルメチル基等である。4-hensyloxybenzyl, 3,4-dimethoxybenzyl, imidasolylmethyl, 3,4-methylenedioxybenzyl, phenyl, 4-hensyloxyphenyl, N
Y-Nitroquanidinoprohil, N'-Boc-7
Mi/butyl, NY-BOC-aminopropyl, indolylmethyl group, etc.
次に本発明方法について説明する。Next, the method of the present invention will be explained.
前記記載の(1)式で示したβ−アミノアルコールある
いはペプチドアルコールの合成法とじては1種々の合成
法を応用することができるが。Various synthetic methods can be applied to the synthesis method of the β-amino alcohol or peptide alcohol shown by the above-mentioned formula (1).
ノール−ベンゼン混合溶媒に溶解し、トリメチルシリル
ジアゾメタンを室温で反応させた後。After dissolving in nor-benzene mixed solvent and reacting with trimethylsilyldiazomethane at room temperature.
反応溶媒を減圧下に留去し1反応容器をアルゴンカス等
で置換した後テトラヒドロフラン・エタノール溶媒に溶
解し、塩化リチウム及び水素化ホウ素すl−IJウムを
加え室温下に反応させるこ吉によって容易にβ−アミノ
アルコールトスることができる。生成物の単離方法とし
ては反応液より溶媒を留去した後、常法に従い塩化メチ
レン等の溶媒で抽出、洗浄、乾燥した後溶媒を留去する
ことによって容易に結晶又は油状物として得ることがで
きる。一方、ペプチドアルコールは常法の手段でペプチ
ドのメチルエステルを得、このものにテトラハイドロフ
ラン、塩化リチウム、水素化ホウ素ナトリウムとエタノ
ールを加え、アルゴンガス下で反応させて得ることがで
きる。得られた生成物はそのまま次σ反応に使用するこ
ともできるが、適当な溶媒。After distilling off the reaction solvent under reduced pressure and replacing the reaction vessel with argon gas, etc., dissolve in tetrahydrofuran/ethanol solvent, add lithium chloride and sodium borohydride, and allow to react at room temperature. β-amino alcohol can be added. The product can be isolated by distilling off the solvent from the reaction solution, followed by extraction with a solvent such as methylene chloride, washing, drying, and then distilling off the solvent to easily obtain it as a crystal or oil. I can do it. On the other hand, peptide alcohol can be obtained by obtaining a methyl ester of a peptide by a conventional method, adding tetrahydrofuran, lithium chloride, sodium borohydride, and ethanol to this and reacting it under argon gas. The obtained product can be used as it is in the next σ reaction, but with a suitable solvent.
例えばn−ヘキサン、酢酸エチル、塩化メチレン、エー
テル・n−ヘキサン、酢酸エチル−n−ヘキサン等で再
結晶精製又は減圧蒸留もしくはカラムクロマトグラフィ
ーで精製を行ない次の反応に使用する方が好ましい。次
に、このβ−アミノアルコールあるいはペプチドアルコ
ールとトリエチルアミンを無水ジメチルスルホキンド中
で混合し三酸化イオウ錯体の無水ジメチルスルホキシド
溶液を添加して酸化すれば光学活性α−アミノアルデヒ
ドあるいはペプチドアルコールが生成する。使用するト
リエチルアミンと三酸化イオウ錯体の量は各々25当量
あれは充分であるが、約3当量使用する条件が適当であ
る。三酸化イオウ錯体としては三酸化イオ白つとビリソ
ン、ンオキサン、トリメチルアミン又はDMF等との錯
体が使用できる。反応時間は数分〜士数分で充分であり
、また反応温度は室温で行なうことができる。溶媒さし
ては無水ツメチルスルホキシドがその働きをするが、必
要によりベンゼン、塩化メチレン等も使用可能である。For example, it is preferable to carry out recrystallization purification using n-hexane, ethyl acetate, methylene chloride, ether/n-hexane, ethyl acetate-n-hexane, etc., or purify by vacuum distillation or column chromatography before use in the next reaction. Next, if this β-amino alcohol or peptide alcohol and triethylamine are mixed in anhydrous dimethyl sulfokind and oxidized by adding a solution of sulfur trioxide complex in anhydrous dimethyl sulfoxide, an optically active α-amino aldehyde or peptide alcohol is produced. . Although it is sufficient to use 25 equivalents of each of triethylamine and sulfur trioxide complex, it is appropriate to use about 3 equivalents. As the sulfur trioxide complex, a complex of sulfur trioxide and virison, oxane, trimethylamine, DMF, etc. can be used. A reaction time of several minutes to several minutes is sufficient, and the reaction temperature can be at room temperature. Anhydrous dimethyl sulfoxide acts as a solvent, but benzene, methylene chloride, etc. can also be used if necessary.
反応終了後反応混合物を氷水中にあけ生成物を適宜の溶
媒9例えばエーテルあるいは酢酸エチル−ベンゼン(4
:l)等に溶解し。After the reaction is complete, the reaction mixture is poured into ice water and the product is dissolved in an appropriate solvent such as ether or ethyl acetate-benzene (4
:l) etc.
クエン酸水溶液、水、飽和重曹水等で洗浄したのち乾燥
し溶媒を留去すると生成物として光学活性α−アミノア
ルデヒド類及びペプチドアルコール類を得る。得られた
光学活性α−アミノアルテヒド類及びペプチドアルデヒ
ト゛類は何ら精製することなく酵素阻害剤等に使用でき
るが結晶性のものは適当な溶媒より再結晶できる。After washing with an aqueous citric acid solution, water, a saturated sodium bicarbonate solution, etc., the mixture is dried and the solvent is distilled off to obtain optically active α-amino aldehydes and peptide alcohols as products. The obtained optically active α-amino aldehydes and peptide aldehydes can be used as enzyme inhibitors, etc. without any purification, but crystalline ones can be recrystallized from a suitable solvent.
以上の如く本発明方法はα−アミノ酸より容易に得られ
るβ−アミノアルコールから簡単な操作で高収率、高光
学純度でα−アミノアルテヒトを製造する新規な方法を
提供するもので。As described above, the method of the present invention provides a novel method for producing α-aminoartechite in high yield and high optical purity using simple operations from β-amino alcohol which is easily obtained from α-amino acid.
以下参考例、実施例を以て本発明を説明するが。The present invention will be explained below using reference examples and examples.
とする。shall be.
Ala : アラニン残基
Val : バリン残基
Leu : ロイシン残基
Pro : プロリフ残基
Met + メチオニン残基
Trp : トリプトファン残基Tyr
: チロシン残基
Lys : リジン残基
Glu ; グルタミン酸残基Cys
: システィン残基
Arg : アルギニン残基
Phe : フェニルアラニン残基o+y
: グリシン残基
Boc : 第三ブトキンカルボニル基Z
: カルボベンツ゛キシ基
Bzl : ベンジル基
No、 : ニトロ基
24−DNP : 2,4−ジニトロフェニルヒドラ
ゾン誘導体py−so、 : 三酸化イオウ・ピリ
ジン錯体OMe : メチルエステル
参考例1. Boc −L−Lys(Z)−olの合
成りoc −L−Lys(Z)−OH380m9(1ミ
リモル)の20%メタノール−ベンゼン溶液に2M−ト
リメチルシリルジアゾメタン−ヘキサン溶液0.7 m
lを5分間で加え、室温で20分間攪拌する。反応溶液
を減圧上留去し9反応容器をアルコンカスで置換し、塩
化リチウム85m9(2m mo+)、水素化ホウ素ナ
トリウム76mp(2ミリモル)とテトラハイドロフラ
ン−エタノール(1: 2容tut)9mlを加え、室
温化−夜攪拌する。反応溶液を減圧下留、去し、10%
クエン酸水溶液10m1を加え塩化メチレン80m1で
8回抽出し、塩化メチレン層を無水芒硝で乾燥する。溶
媒留去後。Ala: Alanine residue Val: Valine residue Leu: Leucine residue Pro: Prolife residue Met + Methionine residue Trp: Tryptophan residue Tyr
: Tyrosine residue Lys : Lysine residue Glu ; Glutamic acid residue Cys
: Cystine residue Arg : Arginine residue Phe : Phenylalanine residue o+y
: Glycine residue Boc : Tertiary butquine carbonyl group Z
: Carbobenzoxy group Bzl : Benzyl group No. : Nitro group 24-DNP : 2,4-dinitrophenylhydrazone derivative py-so : Sulfur trioxide/pyridine complex OMe : Methyl ester Reference Example 1. Synthesis of Boc-L-Lys(Z)-ol 0.7 m of 2M-trimethylsilyldiazomethane-hexane solution in 20% methanol-benzene solution of 380m9 (1 mmol) of oc-L-Lys(Z)-OH
1 over 5 minutes and stirred at room temperature for 20 minutes. The reaction solution was distilled off under reduced pressure, and the reaction vessel was replaced with alcon gas, and 85m9 (2m mo+) of lithium chloride, 76mp (2 mmol) of sodium borohydride, and 9ml of tetrahydrofuran-ethanol (1:2 volume tut) were added. , come to room temperature - stir overnight. The reaction solution was distilled off under reduced pressure, and 10%
Add 10 ml of citric acid aqueous solution, extract 8 times with 80 ml of methylene chloride, and dry the methylene chloride layer with anhydrous sodium sulfate. After evaporating the solvent.
無色の結晶としてBoc−L−Lys(Z)−ofが得
られる。収量858m9(98%)これをエーテル−〇
−へキサンより再結晶し無色針状晶を得た。Boc-L-Lys(Z)-of is obtained as colorless crystals. Yield: 858 m9 (98%) This was recrystallized from ether-〇-hexane to obtain colorless needle crystals.
融点;69〜710C,Cα几0−9.25 (C==
1 、メタノール)
参考例2〜12
参考例1と全く同一条件でBoc −L−Lys (Z
)−OHをBoc −L−Ala −OH(参考例2)
、Boc−L−Vat−OH(8)、 Boc −L−
Leu−OH(4)、Boc −L−Pro−OT((
5)、 Z−L−Pro−OH(6)、Boc−L −
Met−OH(7)、Z−L−Phe−OH(8)、
Z−L−Oys(Bzl)−0H(9)、 Boc−
L−Tyr)−OH(10)、 Boc −L−Tyr
(Bzl)−OH(11)、 Boc −L−Arg(
No2) −014(1,2)に変え各種アミノアルコ
ールを合成した。Melting point: 69-710C, Cα 0-9.25 (C==
1, methanol) Reference Examples 2 to 12 Boc-L-Lys (Z
)-OH to Boc-L-Ala-OH (Reference Example 2)
, Boc-L-Vat-OH (8), Boc-L-
Leu-OH (4), Boc-L-Pro-OT ((
5), Z-L-Pro-OH (6), Boc-L-
Met-OH (7), Z-L-Phe-OH (8),
Z-L-Oys(Bzl)-0H(9), Boc-
L-Tyr)-OH(10), Boc-L-Tyr
(Bzl)-OH(11), Boc-L-Arg(
No. 2) Various amino alcohols were synthesized in place of -014(1,2).
2、 Boc−L−Ala−ol 9B
54〜6℃ −109G>l 、MeOHlA
Boc−L−Vat−ol 90 (105vO
,5m+yt1g) −16,4(0−1,Me(l(
)4、 Boc−L−Leu−of 95 (11
0℃70.5mmHg) −28,8(s 、 tt
)5、 Boc−L−Pro−of 92 (9
0V0.4mml(g) −55,1(p 、 tr
)6、 Z−L−Pro−of Ql
−46,8(rr 、 /l
)?、 Boc−L−Met−of 82 47−
8℃ −21(〃、〃)8、 Z−L−Phe−of
90 89〜92℃ −4]、、?
(0−1匂EtOH)9、 Z−L−Cys(Bzl
)−ol 77 61〜a℃ −135,5(0=
1.MeOI()+0. Hoc−L−Trp−ol
91 118〜120℃ −29,7(n 、 #
)11、 Hoe−L−Tyr(Bzl)−ol
89 98〜100℃ −19,7(1、71)12、
Hoc−L−Arg(Not)−ol 5!l 1
82−4℃−7,45(rr 、 n )実施例1.
Z−L−Phe−alの合成Z−L−Phe−o1
5701Q(2ミリモル)、i・リエチルアミン607
■(6ミリモル)、無水ジメチルスルホキシド6ml溶
液に室温攪拌下、 Py−803955#1p(6ミ
リモル)、無水ジメチルスルホキシド6ml溶液を加え
10分間攪拌し、氷水6oml中に反応溶液をあけ水層
をエーテル+omlで3回抽出し、エーテル層は10%
クエン酸、水、飽和重曹水の順に80m1で2回各々を
洗浄し無水芒硝で乾燥する。溶媒留出後熱色の結晶とし
て2−L −Phe−alが生成物として得られる。収
量567mg(1,00%)、このものをエーテル−〇
/’\キサンより再結晶し無色針状晶を得た。収量4
80■(85%)、融点;77〜9°C9〔α〕習+4
4.5 (C=1、塩化メチレン)
実施例2〜18
実施例1と全く同一条件でZ−L−pHe−01をBo
c−L−Ala−of (実施例2 )、 Boc−
L−Val−at(s)、 Boc−L−Leu−ol
(4)、Boc−L−Pro −0l(5)、 Z−L
−Pro−ol(a)、 Boc −L−Met−of
(7)。2. Boc-L-Ala-ol 9B
54~6℃ -109G>l, MeOHlA
Boc-L-Vat-ol 90 (105vO
,5m+yt1g) -16,4(0-1,Me(l(
) 4, Boc-L-Leu-of 95 (11
0℃70.5mmHg) -28,8(s, tt
)5, Boc-L-Pro-of 92 (9
0V0.4mml(g) -55,1(p, tr
)6, Z-L-Pro-of Ql
−46,8(rr, /l
)? , Boc-L-Met-of 82 47-
8℃ -21(〃,〃)8, Z-L-Phe-of
90 89~92℃ -4],,?
(0-1 EtOH) 9, Z-L-Cys (Bzl
)-ol 77 61~a℃ -135,5 (0=
1. MeOI()+0. Hoc-L-Trp-ol
91 118~120℃ -29,7(n, #
) 11, Hoe-L-Tyr(Bzl)-ol
89 98-100℃ -19,7(1,71)12,
Hoc-L-Arg(Not)-ol 5! l 1
82-4°C-7,45 (rr, n) Example 1.
Synthesis of Z-L-Phe-al Z-L-Phe-o1
5701Q (2 mmol), i. ethylamine 607
Py-803955 #1p (6 mmol) and 6 ml of anhydrous dimethyl sulfoxide were added to a 6 ml solution of anhydrous dimethyl sulfoxide under stirring at room temperature, stirred for 10 minutes, and the reaction solution was poured into 6 oml of ice water and the aqueous layer was evaporated with ether. Extracted 3 times with +oml, the ether layer was 10%
Each was washed twice with 80 ml of citric acid, water, and saturated sodium bicarbonate solution in that order, and dried with anhydrous sodium sulfate. After distillation of the solvent, 2-L-Phe-al is obtained as a product as hot-colored crystals. The yield was 567 mg (1,00%), and this product was recrystallized from ether-〇/'\xane to obtain colorless needle crystals. Yield 4
80■ (85%), melting point; 77-9°C9 [α] +4
4.5 (C=1, methylene chloride) Examples 2 to 18 Bo
c-L-Ala-of (Example 2), Boc-
L-Val-at(s), Boc-L-Leu-ol
(4), Boc-L-Pro-0l (5), Z-L
-Pro-ol(a), Boc-L-Met-of
(7).
Boc −L−Trp−of(8)、 Boc −L−
Tyr(Bzl)−of(9)、 Boc −L−L
ys(Z)−of(10)、 Z−L−Cys(Bz
l)−of(11)、 Boc −L−Arg(No2
) −ol(12)。Boc-L-Trp-of(8), Boc-L-
Tyr(Bzl)-of(9), Boc-L-L
ys(Z)-of(10), Z-L-Cys(Bz
l)-of(11), Boc-L-Arg(No2
) -ol(12).
Boc −L−Glu(Bzl )−ol(18)に変
え各種α−アミノアルデヒドを合成した。Various α-amino aldehydes were synthesized in place of Boc-L-Glu(Bzl)-ol (18).
0
実施例 収率(至) 融点 再結晶溶媒
〔α〕02Boc−L−Ala
j−−チル” n +88.9−at 66
90−2℃ −ヘキサン (O−1,塩化メチ〃
)a Boc−L−V a I s a※15.6
℃ +198−@I
(#、 l)4B0cm
L−Leu86へ61〜3℃ +184
−11 (
/7. tt )5Boc−L−Pr。0 Example Yield (to) Melting point Recrystallization solvent
[α]02Boc-L-Ala
j--chill” n +88.9-at 66
90-2℃ -Hexane (O-1, Methyl chloride)
) a Boc-L-V a I s a *15.6
℃ +198-@I
(#, l)4B0cm
To L-Leu86 61~3℃ +184
-11 (
/7. tt)5Boc-L-Pr.
−,+ 84 (油状)(0=1 、 / 9/
−Jl/)6Z−L−Pro96※18B〜5℃
−781−1(Q−1,塩化メ月〃)
7Boc−L−Me t o o※14ト2℃
+278−at
(#、 # )8 ””
”p85 、 84−7℃ エーテJ”n +42
U−・1 −ヘキサン (n、y)
、 Boc−L−Tyr
+46.2(Bzl)−轡、8198″″10
0℃ “ (□、〃)l、、 Boc−L
−Lys +24.
9(Z)−at 77 78−80℃
(#、 tr )llZ−L−Cys−L
−101
(Bzl )−sl+ 78 105−112℃
” (#、/I)lzBoc−L−Arg
(NO2)−al gI21a8〜1411: 酢酸
x%vx−7′b +27.9−n−ヘキサン (
C−+、 ρMF )18Boc−L−Glu
(Bzl)−al ss 111−113℃x−fpv
−n−64+24.11サン (C=
1.塩化ノーf−F//)※印は2.4〜DNPにした
時の融点である。−, + 84 (oily) (0=1, / 9/
-Jl/)6Z-L-Pro96*18B~5℃
-781-1 (Q-1, chloride) 7Boc-L-Me to o*14 to 2℃
+278-at
(#, #)8 ””
"p85, 84-7℃ Aete J"n +42
U-・1-hexane (n,y)
, Boc-L-Tyr
+46.2 (Bzl) - 轡, 8198″″10
0℃ " (□, 〃)l,, Boc-L
-Lys +24.
9(Z)-at 77 78-80℃
(#, tr)llZ-L-Cys-L
-101 (Bzl)-sl+ 78 105-112℃
” (#, /I)lzBoc-L-Arg (NO2)-al gI21a8~1411: Acetic acid x%vx-7'b +27.9-n-hexane (
C-+, ρMF)18Boc-L-Glu (Bzl)-al ss 111-113℃x-fpv
-n-64+24.11 suns (C=
1. Chloride No f-F//) *mark is the melting point when it is made from 2.4 to DNP.
Claims (1)
、官能基の全部又は一部を保護したアミノ酸残基または
ペプチド残基、R2及びR4は水素原子又はアルキル基
、R3は水素原子、アルキル基もしくはアリール基であ
り、アルキル基及びアリール基は無置換であってもよく
置換されていてもよい)で示される光学活性β−アミノ
アルコール類にジメチルスルホキシド中トリエチルアミ
ン存在下三酸化イオウ錯体を反応させることを特徴とす
る一般式 で示される光学活性α−アミノアルデヒF類の製造法。(1) General formula (in the formula, amine protecting group, amino acid residue, peptide residue, amino acid residue or peptide residue with all or part of the functional group protected, R2 and R4 are hydrogen atoms or alkyl groups, R3 is a hydrogen atom, an alkyl group, or an aryl group, and the alkyl group and the aryl group may be unsubstituted or substituted) in the presence of triethylamine in dimethyl sulfoxide. A method for producing optically active α-aminoaldehydes F represented by the general formula, which comprises reacting a sulfur trioxide complex.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57031818A JPS58150556A (en) | 1982-03-02 | 1982-03-02 | Preparation of optically active alpha-aminoaldehyde |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57031818A JPS58150556A (en) | 1982-03-02 | 1982-03-02 | Preparation of optically active alpha-aminoaldehyde |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58150556A true JPS58150556A (en) | 1983-09-07 |
JPH0229670B2 JPH0229670B2 (en) | 1990-07-02 |
Family
ID=12341664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57031818A Granted JPS58150556A (en) | 1982-03-02 | 1982-03-02 | Preparation of optically active alpha-aminoaldehyde |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58150556A (en) |
-
1982
- 1982-03-02 JP JP57031818A patent/JPS58150556A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0229670B2 (en) | 1990-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005105826A1 (en) | Tyropeptin a analogue | |
JPH06340691A (en) | Peptide | |
US5510333A (en) | Inhibitors of Cathepsin G and elastase for preventing connective tissue degradation | |
FR2609289A1 (en) | NOVEL COMPOUNDS WITH ACTIVITY OF COLLAGENASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | |
Hiskey et al. | Sulfur-Containing Polypeptides. I. Use of the N-Benzhydryloxycarbonyl Group and the Benzhydryl Ester1, 2 | |
JPH06501681A (en) | Inhibitors of retroviral proteases | |
Zanotti et al. | Synthesis of analogues of amaninamide, an amatoxin from the white Amanita virosamushroom | |
CA1104156A (en) | Analogues of bestatin | |
US4980287A (en) | 4H-3,1-benzoxazin-4-one compounds and pharmaceutical compositions thereof for the inhibition of serine proteases | |
FR2471411A1 (en) | NOVEL A-HYDROXYTRIPEPTIDE SUBSTRATES USEFUL AS REAGENTS FOR THE DETERMINATION OF PROTEOLYTIC ENZYMES | |
IE42785B1 (en) | L-3-(3,4-dihydroxyphenyl)-2-methyl-alanine peptides | |
CA1336349C (en) | Nitrogenous polycyclic tripeptides, their preparation and pharmaceutical compositions containing them | |
JPS58150556A (en) | Preparation of optically active alpha-aminoaldehyde | |
US4257939A (en) | Peptide derivative | |
US3891692A (en) | N-(cyclopropylalkoxycarbonyl)amino acids | |
FI119641B (en) | Tetrapeptides useful as intermediates and therapeutically active compounds and their preparation | |
JPH0548237B2 (en) | ||
US4283328A (en) | Preparation of dehydropeptides | |
US4350628A (en) | Preparation of dehydropeptides | |
US3948971A (en) | N-protected-α-amino acid compounds | |
WO2000024704A1 (en) | Process for producing peptidyl aldehydes | |
US4261884A (en) | Preparation of dehydropeptides | |
JPS61106569A (en) | Intermediates for branched chain amides of l-aspartyl-d-amino acid dipeptide | |
JP3997141B2 (en) | Tyropeptin A analog | |
JPH02209865A (en) | Preparation of antihypertensive drug |